In A Nutshell High-throughput drug screening identified rigosertib as highly selective for ovarian cancer cells. Alone, ...

A new FDA application for relacorilant shows promising survival benefits in treating platinum-resistant ovarian cancer, ...

The response rate was higher in those with a KRAS mutation at 44%, compared to 17% in KRAS wild-type patients.

High BMI may raise ovarian cancer risk in premenopausal women due to hormonal imbalance and insulin resistance.

Saul Rivkin lost his wife Marsha to Ovarian Cancer in 1993. To honor her memory and to raise money for research, he founded ...

A dedicated husband and carer has revealed the silent signs of a deadly cancer that kills thousands of women each year, ...

Corcept Therapeutics has filed for U.S. Food and Drug Administration approval of its relacorilant drug candidate for the treatment of patients with platinum-resistant ovarian cancer.

Taylor and wife Haley had many conversations to prepare for the future, which the dad honors as he raises their son ...

A woman who lost her sister to cervical cancer said her life was saved after it spurred her to undergo an early health ...

Colorado’s poet laureate, Andrea Gibson of Boulder, died at their home early Sunday, July 14, from ovarian cancer. They were ...

A Kolkata teacher beats Stage IV ovarian cancer with advanced surgery, genetic testing, and targeted therapy—while inspiring ...

Olivia Munn and her mothers breast cancer journey highlights the importance of using breast cancer risk assessment tools like ...